Chair: Dr Fozia Ahmed | Manchester, UK | |||
---|---|---|---|---|
Organisational Issues | ||||
Implications of national cardiology GIRFT report for CRM - is it realistic or aspirational (or delusional)? | ||||
Device follow up 2021 - what is frequency of optimal device follow up | Dr John Paisey | Southampton, UK | ||
Remote monitoring for all - implications and affordability for a bradycardia population | Mr Stuart Allen | Manchester, UK | ||
Should leadless pacemakers be new standard of care in bradycardia pacing - implications for UK practice: Present and future | Dr Chris Pepper | Leeds, UK | ||
Chair: Dr Honey Thomas | Northumbria, UK | |||
Pacing | ||||
Cardiac pacing - His bundle, septal and LBBB pacing or keep it simple | ||||
Clinical evidence and Implant challenges | ||||
Device complications - how to minmise risk | Dr Honey Thomas | Northumbria, UK | ||
Challenging device cases - Venoplasty tips and tricks | ||||
MRI and cardiac devices - why is this still an issue? | ||||
Chair: Dr Guy Haywood | Plymouth, UK | |||
Miscellaneous | ||||
ECG - practical tips and tricks for the non specialist | ||||
Cardiac anatomy for CRM specialist | ||||
Arrhythmias during pregnancy | Dr Dawn Adamson | Coventry, UK | ||
Ventriuclar ectopy - when to worry and management options | Dr Lee Graham | Leeds, UK | ||
Arrhythmias in Athletes: What to Do? | Dr David Begley | Cambridge, UK | ||
Chair: | ||||
ICD Therapy | ||||
Primary prevention ICD therapy - time for a rethink | ||||
Dilated cardiomyopathy - what is OMT in 2021 | ||||
LV remodelling - when to decide on device therapy in DCM | Prof Roy Gardner | Glasgow, UK | ||
Predicting SCD: Beyond EF | Prof Andre Ng | Leicester, UK | ||
ATP or no ATP for primary prvention ICDs |
Chair: Prof Dhiraj Gupta, Prof Tim Betts | Liverpool, UK, Oxford, UK | |||
---|---|---|---|---|
Pulsed field ablation of AF | Prof Pierre Jais | Bordeaux, FR | ||
Advances in leadless pacing | Dr Vivek Reddy | New York, US | ||
COVID-19 and remote monitoring - lessons for the future | Ms Cristiana Monteiro | Oxford, UK | ||
Cardiac radiotherapy for VT | ||||
Wearable technology in heart failure | ||||
Laser ablation | Dr Scott Gall | Blackpool, UK |
Chair: | ||||
---|---|---|---|---|
Ventricular arrhythmia | Dr John Sapp | Halifax, CA | ||
AF | ||||
Whats on the horizon – the next 24-26 months |
Chair: | ||||
---|---|---|---|---|
Bradycardia | Prof Kenneth Ellenbogan | Richmond, US | ||
ICDs / CRT | ||||
Syncope | Prof Robert Sheldon | Calgary, CA |
Chair: Prof Richard Schilling | London, UK | |||
---|---|---|---|---|
Should we adopt a comprehensive characterisation of AF patients | ||||
How much can AF be managed by adopting a healthy lifestyle? | ||||
How do we pick rhythm control for our AF patients? | Prof Paulus Kirchhof | Hamburg, DE | ||
How much can the AF patient be involved in making management decisions? |
Chair: Dr Derick Todd, Prof Tim Betts | Liverpool, UK, Oxford, UK | |||
---|---|---|---|---|
What QoL reduction related to AF is necessary to make ablation a worthwhile procedure and how do we measure it? | Dr Kim Rajappan | Oxford, UK | ||
What should we do in addition to PVI for 1st time persistent AF – the posterior box or something else? | Prof Dhiraj Gupta | Liverpool, UK | ||
How to judge when can we stop anticoagulants in post AF ablation when CHADSVASc>1 | Prof John Camm | London, UK | ||
Should LAAO isolation & occlusion be part of treatment for persistent AF? | Dr Dhanunjaya Lakkireddy | Kansas, US | ||
AF ablation to treat heart failure. Therapy or futility? | Prof Pier Lambiase | London, UK | ||
Do better lesions mean better outcomes? Power, force or electroporation – what is the answer? | Prof Helmut Puererfellner | Linz, AT | ||
How to define AF substrate: Voltage, velocities or late LGE and does it help guide ablation? | ||||
How to map atrial fibrillation and identify targets for ablation | Dr Tom Wong | London, UK | ||
Chair: Dr Shouvik Haldar | London, UK | |||
AF ablation as first line therapy - Debate (Pro) | Dr Derick Todd | Liverpool, UK | ||
AF ablation as first line therapy - Debate (Con) | Dr Hugh Calkins | Baltimore, US | ||
Chair: Prof Andre Ng | Leicester, UK | |||
Cryo ablation should be the index ablation for all (Pro) | Dr Jason Andrade | Vancouver, CA | ||
Cryo ablation should be the index ablation for all (Con) | Dr Damian Redfearn | Kingston, CA |
Chair: Dr Alistair Slade, Prof Derek Connelly | Truro, UK, Glasgow, UK | |||
---|---|---|---|---|
Ablate & Pace – the evidence | ||||
Patient selection – is it only for failed AF ablation and permanent AF? | ||||
Which CRT patients need AV nodal ablation? And which AV nodal ablation patients need CRT? | ||||
AV nodal ablation and His bundle pacing – Who, how and why? | Prof Haran Burri | Geneva, CH | ||
Programming issues – lower rate limit, mode switching, sensor issues |
Chair: Lord Ajay Kakkar | London, UK | |||
---|---|---|---|---|
GLORIA | ||||
GARFIELD | ||||
ORBIT | ||||
PREFER IN AF |
Chair: Dr Niall Campbell | Manchester, UK | |||
---|---|---|---|---|
Post operative AF - Who, how and how to prevent | ||||
Risk stratification using risk scores - where are we now? |
Chair: Prof John Camm | London, UK | |||
---|---|---|---|---|
2021 EHRA practical NOAC guide for AF (New edition) | ||||
AF, dementia and oral anticoagulation | ||||
AF, diabetes mellitus and oral anticoagulant | ||||
AF, chronic kidney disease and oral anticoagulants | Prof Reinhold Kreutz | Berlin, DE |
Chair: Mr Ian Wright | London, UK | |||
---|---|---|---|---|
When you don't need an EP study to know the diagnosis | ||||
The origin of the different pacing manoeuvres we use in EP | ||||
When its easy to get the diagnosis wrong | ||||
Focal or re-entrant? Response to entrainment and other clues | Dr Nick Linton | London, UK |
Chair: | ||||
---|---|---|---|---|
Ablation from the aortic root: ATs, VTs and Pathways | ||||
Protecting the phrenic nerve during ablation | ||||
Mapping and ablation of papillary muscle VEs | ||||
High power RF ablation: the way forward? | Prof Andre Ng | Leicester, UK |
Chair: | ||||
---|---|---|---|---|
What's new in the ESC HF2021 guideline: diagnosis | ||||
What's new in the ESC HF2021 guideline: treatment | ||||
Atrial fibrillation and HF: do we know what we should do? | ||||
ICDs for patients with Heart Failure: do we still need them? |
Chair: Dr Alistair Slade, Dr Ashley Nisbet | Truro, UK, Bristol, UK | |||
---|---|---|---|---|
National audit of CRM devices and ablation: key findings from the latest report | ||||
Patient reported outcomes in Cardiac Rhythm Management – what’s coming? | ||||
Use of national registry for device surveillance | ||||
What can NICOR do for your centre? New online tools for you to check your data and benchmark your centre | ||||
How can our CRM audit data be used by the NHS in the future? Linkage with other sources to improve outcomes? |
Chair: Prof Aldo Rinaldi | London, UK | |||
---|---|---|---|---|
Lessons learned in designing and executing lean, cost-effective trials | ||||
How to do a meta-analysis and systematic review-The do's and the don'ts | ||||
What are the top tier journals looking for in an EP/Devices paper? | ||||
Public-patient involvement in research-How to do it | ||||
Life as an Arrhythmia Research Nurse- a career worth considering? |